Does ASTC pay a dividend and is it safe?

Astrotech Corporation (ASTC) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Stock Ratings / Health Care / ASTC / dividends

BNGO (29) EYPT (26) PRPO (30) RPID (34) ⌘ Pro Terminal →

Astrotech Corporation (ASTC) Dividend Safety Gauge & 10-Year DRIP Compounder

$4.71 -2.69% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $4.68

Astrotech Corporation (ASTC) carries a Roarable Rating of E (Strong Sell) with 28/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $10.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ASTC Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ASTC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Astrotech Corporation (NASDAQ: ASTC) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 28/100 at a spot price of $4.71 (-2.69% 1D, market cap $10.2M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, ASTC ranks #872 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ASTC compare to BNGO and EYPT in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Laboratory Analytical Instruments), ASTC carries a Roarable E (28/100 RQD), trailing P/E of N/A, gross margin of 47.5%, and ROIC of -35.0%. By comparison, BNGO (Bionano Genomics Inc.) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $16.1M) and EYPT (EyePoint Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $30.0M). Among the 5-stock peer group, ASTC leads on earnings multiple (N/A) while PRPO leads on capital efficiency (-7.9% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ASTC?

▼

Per ASTC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001001907), Astrotech Corporation generated $1.0M in revenue (-41.2% YoY), -$13.8M in net income, and -$13.8M in free cash flow against $19.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $4.68 (-0.67%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (28/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.0% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-13.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ASTC)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (28/100 Composite)

🔍 WHY ASTC SCORES 28/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (29% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (29% of score)

FRED Regime × Technicals: 4% of 52W Range • RSI-14 at 35 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$6.06-19.6% Next Q

Q2 (-2Q)

Grade E$4.87+7.4% Next Q

Q3 (-1Q)

Grade E$5.23-9.9% Next Q

Current

Grade E$4.71-10% Hist 90D α

Trajectory: E (36) → E (28)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ASTC Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ASTC currently carries a cautious 28/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.40) and Max Pain ($4.95) forces dealer call-delta covering toward $72.29.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ASTC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ASTC Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”

YES 28%NO 72%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $307/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.1K

Yr 2

$11.7K

Yr 3

$12.4K

Yr 4

$13.1K

Yr 5

$13.8K

Yr 6

$14.5K

Yr 7

$15.3K

Yr 8

$16.2K

Yr 9

$17.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ASTC)

✓Walkthrough of ASTC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ASTC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +62.98%⚡ TESTING RESISTANCE

2026-11-03O $5.25H $5.25L $4.71C $4.71VOL 17.9K

RES: $4.93SUP: $4.04SMA50: $6.40SMA200: $7.22

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ASTC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ASTC Butterfly Map → + Track ASTC →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. -41.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on ASTC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ASTC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ASTC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ASTC)

Health Care Rank #872 of 1015 ⚔️ BNGO vs ASTC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ASTC vs. BNGO, EYPT, PRPO, RPID)

Industry: Biotechnology: Laboratory Analytical Instruments (21 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Astrotech Corporation (ASTC) ranks #872 by composite RQD confidence (28/100, grade E) and #889 by equity capitalization ($10.2M). Within this direct 5-issuer industry benchmark cohort, ASTC leads on earnings valuation at N/A trailing P/E, while PRPO leads on capital efficiency and profitability with -7.9% ROIC and 44.2% gross margin. RPID currently holds the highest overall quantitative score in the immediate peer group at 34/100 (E) compared with ASTC at 28/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ASTC ACTIVE Astrotech Corporation	E	28/100	—	47.5%	-35.0%	-2.69%	$10.2M	Benchmark Subject
BNGO Bionano Genomics Inc.	E	29/100	—	46.3%	-35.0%	+0.87%	$16.1M	/bngo-vs-astc →
EYPT EyePoint Inc.	E	26/100	—	—	-35.0%	+7.58%	$30.0M	/eypt-vs-astc →
PRPO Precipio Inc.	E	30/100	—	44.2%	-7.9%	-1.71%	$32.4M	/prpo-vs-astc →
RPID Rapid Micro Biosystems Inc. (Class A)	E	34/100	—	—	-35.0%	-4.50%	$36.9M	/rpid-vs-astc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001001907 ↗

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Astrotech Corporation (ASTC) reported GAAP revenue of $1.0M (-41.2% vs. FY2024 revenue of $1.7M , and +33.3% cumulative change since FY2023) , GAAP net income of -$13.8M, operating cash flow of -$13.0M, and free cash flow of -$13.8M (-33.8% YoY). On the balance sheet, ASTC closed FY2025 with $19.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$1.0M	-$13.8M	-$13.0M	-$13.8M	$19.7M	—
FY2024 (FY)	2024-06-30	$1.7M	-$11.7M	-$9.7M	-$10.3M	$31.0M	—
FY2023 (FY)	2023-06-30	$750.0K	-$9.6M	-$7.6M	-$7.6M	—	—

3. ASTC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ASTC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does ASTC compare to BNGO and EYPT in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for ASTC?

Where is ASTC trading relative to its 50-day, 200-day, and 52-week technical levels?

ASTC last traded at $4.71 (-2.69% on volume of 31,223 shares), positioning the stock -26.41% below its 50-day simple moving average ($6.40) and -34.76% below its 200-day simple moving average ($7.22). Across its 52-week range of $1.92 to $68.85, ASTC sits at the 4.2% percentile with a 14-day RSI of 35.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.12 to $5.30).

Direct Sub-Reports: ASTC RQD Cockpit ASTC 12M Forecast ASTC Earnings & Move ASTC Dividends & DRIP ASTC Insiders & 13F ASTC Whale Options ASTC Profit Sankey ASTC News & Why

ROARABLE RATING BRIEF • RQD 28/100 (E) ✓ SEC XBRL & RQD VERIFIED

ASTC — Astrotech Corporation: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-06-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Astrotech Corporation (ASTC) earns a live Roarable RQD composite score of 28/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $4.71 (-2.69% 1D, market capitalization $10.2M).

Fundamental Cash Engine (6/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 47.5%, operating margin of -60.0%, and free cash flow yield of —.
Whale 13F & Options Flow (3/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (8/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 3/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Astrotech Corporation (ASTC) is a NASDAQ-listed issuer in the Health Care sector, operating in the Biotechnology: Laboratory Analytical Instruments industry. Gross margin is reported at 47.5%, while operating and net margins are both reported at -60%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-06-30), Astrotech Corporation (ASTC) reported $1.0M in annual revenue (up from $1.7M in FY2024, -41.2% YoY) and -$13.8M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($750.0K revenue, -$9.6M net income) through FY2025, ASTC scaled operating cash flow to -$13.0M and free cash flow to -$13.8M, backed by $19.7M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (E • RQD 28/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 6/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $1.92 – $68.85 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The only sector-level context provided is the Health Care sector and Biotechnology: Laboratory Analytical Instruments industry classification. A prospective investor should watch whether the NASA-related lunar infrastructure proposal translates into revenue, since the source does not establish any link between that activity and the reported health-care industry classification.

Key Question #1: Can ASTC sustain or expand its -60.0% operating margin and -35.0% ROIC against Biotechnology: Laboratory Analytical Instruments peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $1.0M and free cash flow of -$13.8M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is ASTC's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

ASTC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Astrotech Corporation (ASTC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ASTC Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 21h ago

Astrotech Makes Proposal to Provide Advanced Lunar Power Infrastructure Under NASA NextSTEP-3 Program

Yahoo Finance report covering Astrotech Corporation (ASTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

At least $20M in sale value is needed for 1st Detect bonuses under Astrotech (ASTC)'s new plan.

Stock Titan report covering Astrotech Corporation (ASTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com Nigeria • 1d ago

Form 4 Astrotech Corp: Tom Wilkinson (Director) For: 30 September By Investing.com

Investing.com Nigeria report covering Astrotech Corporation (ASTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Stock Traders Daily • 1d ago

Discipline and Rules-Based Execution in ASTC Response

Stock Traders Daily report covering Astrotech Corporation (ASTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago

Astrotech (ASTC) Slips 1.92% to $5.10, Testing the Lower Half of Its Recent Range - Fibonacci Fan

https://www.dars.gov.et/ report covering Astrotech Corporation (ASTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE The Manila Times • 1d ago

Innventure Welcomes Eric Stober as Chief Financial Officer

The Manila Times report covering Astrotech Corporation (ASTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Benzinga • 14d ago

Astrotech Submits Proposal For The NASA Next Space Technologies For Exploration Partnerships-3 Lunar Enabling Infrastructure Accelerator Regarding Its Vertical Solar Array

The proposed project, Astrotech Vertical Solar Array Maturation (AVSAM), would advance critical elements of the Astrotech Mobile Power System (AMPS) for potential future lunar surface use.The proposal targets maturation

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 19d ago

12 Information Technology Stocks Moving In Thursday's Intraday Session

Gainers Republic Power Group (NASDAQ:RPGL) stock moved upwards by 55.5% to $24.09 during Thursday's regular session. The company's market cap stands at $44.9 million. Alpha Modus Holdings (NASDAQ:AMOD) shares

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ASTC Bull vs. Bear Conversation Board — What's Your Call at $4.71?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ASTC 🐻 33% BEARISH CONVICTION

SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $5.57 (+15.1%)

📌 Pinned Debate

Recent news flow includes a NASA NextSTEP-3 lunar power infrastructure proposal, a potential new revenue avenue not reflected in the re

Recent news flow includes a NASA NextSTEP-3 lunar power infrastructure proposal, a potential new revenue avenue not reflected in the reported financials.. When you look under the hood at ASTC, Fundamental Cash Engine is 6/20 with 47.5% gross margins and -35.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (3/20) has been quietly accumulating below $68.85. My 12M target is $5.57.

SectorRotator 🐂 BULL

@SiliconVal_Bull Agree on the RQD 28/100 quality, though with 1.0 beta I'm scaling in with half-size at $4.84 and keeping dry powder in case we test $4.50.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $3.82 (-21.1%)

Spot @ $4.84

Operating losses widened every year from -$11.1M to -$14.7M while revenue fell to $1.0M, and the RQD cash-engine pillar scored 6/20.

Fading this rally in ASTC at $4.84. Operating losses widened every year from -$11.1M to -$14.7M while revenue fell to $1.0M, and the RQD cash-engine pillar scored 6/20.. With a beta of 1.0 and the stock sitting at $4.84 (52-wk range $1.92–$68.85), the easy multiple expansion is already priced in.